SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Biotech Showcase 2023
Event | 01. 10. 2023
Elizabeth Kelly will be participating on a panel titled "Finance Trends in Asia Pacific" on Tuesday, January 10th at the Biotech Showcase 2023 in San Francisco.
